Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Precancerous Conditions 9Lymphoma 9Leukemia, Myeloid, Acute 9Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia 9Myelodysplastic Syndromes 8Primary Myelofibrosis 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms, Plasma Cell 7Myeloproliferative Disorders 7Multiple Myeloma 7Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Accelerated Phase 7Burkitt Lymphoma 7Lymphoma, T-Cell, Cutaneous 6Lymphoma, Large-Cell, Anaplastic 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Biphenotypic, Acute 6Immunoblastic Lymphadenopathy 6Hodgkin Disease 6Waldenstrom Macroglobulinemia 5Thrombocythemia, Essential 5Polycythemia Vera 5

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × Cyclophosphamide × Other neoplasm × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡